Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1174 of 6351
-
Custom-Made genetic drug targets rare brain disorder in one patient
Disease control OngoingThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with Autosomal Dominant Leukodystrophy (ADLD) due to LMNB1 mutation
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can DIY insulin algorithms match commercial systems for pregnant women with type 1 diabetes?
Knowledge-focused Recruiting nowThe goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
New hope for kids with arthritis: experimental drug enters final testing phase
Disease control Recruiting nowThe purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New pill could help men keep their hair
Disease control OngoingThis study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormone) that causes hair loss. VDPHL01 8.5 …
Phase 3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Sound waves to lift mood? new study tests ultrasound for depression
Symptom relief OngoingThis study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitorin…
Phase 1/2 • Sponsor: Brian Mickey • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Blood test may flag hidden kidney disease risk before damage is done
Diagnosis Recruiting nowClinical Performance Study SP2024001, is a prospective, interventional study to assess the clinical performance of the APOL1 Genotyping Clinical Trial Assay (CTA) in the intended use population and environment. The study will use the APOL1 Genotyping CTA to test deoxyribonucleic …
Sponsor: Almac Diagnostic Services LLC • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Smartphone therapy: could an app help men with HIV kick stimulants?
Disease control Recruiting nowThe purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Sponsor: University of Miami • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug milsaperidone aims to boost depression treatment
Symptom relief Recruiting nowThe purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can Mix-and-Match lenses improve vision after cataract surgery?
Knowledge-focused Recruiting nowThis longitudinal observational study aims to evaluate long-term visual adaptation trajectories, optical quality, and patient-reported outcomes in age-related cataract patients following bilateral implantation of multifocal or mix-and-match intraocular lenses (IOLs). Patients wil…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New hope for HER2+ breast cancer: switching drug combos after treatment fails
Disease control Recruiting nowThis study adopts a multicenter, natural selection, observational design, and plans to enroll patients with HER-2 positive advanced or metastatic breast cancer treated at approximately 20 research centers nationwide. Patients with de novo stage IV disease or those with recurrent …
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New imaging agent targets LRRC15 to sharpen cancer diagnosis
Diagnosis CompletedHere's a polished version of the text: "This project involves patients with high-expression LRRC15 malignant tumors who are either clinically suspected of or diagnosed with pancreatic cancer, breast cancer, lung cancer, ovarian cancer, head and neck tumors, colorectal cancer, me…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
AI eye doctor: new tool aims to spot rare retinal diseases
Diagnosis Completedwe present FM-IRD(also designated as Retina4IRD), the first foundation model-based AI system specifically designed for genotype diagnosis of IRD by emulating clinician decision-making reasoning process. Retina4IRD is capable of processing multimodal input including color fundus p…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Eye drops may offer a new way to read without glasses — a trial puts them to the test
Symptom relief CompletedThis study was to compare the presbyopia correction effect between the treatment group and the control group, evaluated by the proportion of patients who achieved an improvement of 3 lines or more in mesopic binocular DCNVA at post-dose after 4 weeks of administration of the inve…
Phase 3 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New device aims to prevent kidney failure after heart surgery
Prevention OngoingThe goal of this clinical trial is to assess the effect of RenalGuard Therapy in reducing the rates of Acute Kidney Injury (AKI) within 72 hours after cardiac surgery in patients at risk of developing Cardiac Surgery Associated AKI (CSA-AKI) compared to standard-of-care (SoC). P…
Sponsor: CardioRenal Systems, Inc. • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New cocktail of chemo and immunotherapy aims to fight advanced ovarian cancer
Disease control Recruiting nowthis is a trial evaluating three chemotherapy agents in patients with newly diagnosed ovarian cancer patients that are Stage III or Stage IV prior to surgery to remove the tumor. After surgery there will be additional chemotherapy given.
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental drug pacritinib takes aim at rare inflammatory VEXAS syndrome
Disease control Recruiting nowVEXAS (vacuoles, E1 ubiqutin-activating enzyme, X-linked, autoinflammatory, somatic syndrome) is a recently described disorder with severe hematologic and rheumatologic manifestations caused by somatic variants in the ubiquitin- activating enzyme gene, UBA1, that is acquired in h…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New program aims to stop hospital stays from robbing seniors of independence
Disease control OngoingIatrogenic dependence linked to hospitalisation DILH is very frequent, severe but avoidable in 80% of cases. Extensive research has identified 6 main causes of DILH in the elderly, which interact and have common risk factors: immobilisation, falls, undernutrition, de novo urinary…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Heart failure breakthrough? trial tests stopping Beta-Blockers in recovered patients
Disease control Recruiting nowA significant proportion of patients initially diagnosed with heart failure and a reduced left ventricular ejection fraction (LVEF\<40%, HFrEF) presents a substantial improvement in response to evidence-based medical and device therapies. Some of these patients (estimated from 20…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a tiny stent replace pills for prostate trouble?
Symptom relief Recruiting nowThe goal of this study is to determine the safety and effectiveness of the FloStent, a medical device used to treat men with symptoms of Benign Prostatic Hyperplasia, compared to sham (procedure without deployment of the FloStent). All participants will undergo a flexible cystosc…
Sponsor: Rivermark Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Ketamine study probes brain chemistry for depression clues
Knowledge-focused Recruiting nowThe purpose of this study is to to evaluate the relationships between peak (% change from baseline) central GABA and Glu levels during a 40-min IV ketamine or normal saline infusion utilizing fMRS, and change in peripheral GABA and Glu levels from baseline to 24-hr postinfusion u…
Phase 2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC